1. Home
  2. FOXX vs TELA Comparison

FOXX vs TELA Comparison

Compare FOXX & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Foxx Development Holdings Inc.

FOXX

Foxx Development Holdings Inc.

HOLD

Current Price

$4.74

Market Cap

34.0M

Sector

N/A

ML Signal

HOLD

Logo TELA Bio Inc.

TELA

TELA Bio Inc.

HOLD

Current Price

$0.77

Market Cap

36.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOXX
TELA
Founded
2017
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.0M
36.7M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
FOXX
TELA
Price
$4.74
$0.77
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$3.31
AVG Volume (30 Days)
13.2K
329.4K
Earning Date
02-13-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$62,266,756.00
$77,055,000.00
Revenue This Year
N/A
$18.41
Revenue Next Year
N/A
$15.20
P/E Ratio
N/A
N/A
Revenue Growth
44.85
12.24
52 Week Low
$1.71
$0.68
52 Week High
$8.88
$2.96

Technical Indicators

Market Signals
Indicator
FOXX
TELA
Relative Strength Index (RSI) 55.66 29.66
Support Level $4.66 $0.76
Resistance Level $5.15 $0.86
Average True Range (ATR) 0.31 0.12
MACD 0.02 -0.01
Stochastic Oscillator 70.34 12.72

Price Performance

Historical Comparison
FOXX
TELA

About FOXX Foxx Development Holdings Inc.

Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals. The company's current revenue stream is derived from the sales of tablets and smartphones.

About TELA TELA Bio Inc.

TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.

Share on Social Networks: